Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Generic drugs refer to drugs that have the same chemical composition as existing branded drugs. These drugs are cheap and comparable to brand-name drugs in terms of dosage, strength, route of administration, quality, performance and application. Generic drugs are subject to national government regulations, rather than being associated with specific companies.
From 2019 to 2026, the global generic drug market will grow from USD 384.6 billion in 2019 to USD 683.2 billion in 2026, and will grow at a CAGR of 8.55% during the forecast period.
The main factors contributing to the growth of the generic drug market include the increase in the prevalence of chronic diseases, diabetes and cardiovascular diseases, the growth of the elderly population, the increase in health care expenditures, the strong demand for generic drugs and a large number of expired patent and trademark drugs. Many positive measures taken by governments to promote the use of generic drugs are expected to provide impetus to market growth. Some regulatory agencies are conducting rigorous reviews to ensure that the best standards are met in the production of these drugs.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Generic Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Generic Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Generic Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Pfizer (Hospira)
Valeant
Apotex
Stada Arzneimittel
Mylan
Cipla
Zydus Cadila
Lupin
Fresenius Kabi
ENDO (Par Pharmaceutical)
Nichi-Iko Pharmaceutical
Novartis - Sandoz
Aurobindo
Krka Group
Sun Pharmaceutical
Aspen
Hikma
Teva
Sanofi
By Type:
Oral
Injectables
Dermal/Topical
Inhalers
By End-User:
Hospital Pharmacies
Retail Pharmacies
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Generic Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Generic Drugs Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.2 USA Generic Drugs Market Size and Growth Rate of Injectables from 2016 to 2027
-
1.3.3 USA Generic Drugs Market Size and Growth Rate of Dermal/Topical from 2016 to 2027
-
1.3.4 USA Generic Drugs Market Size and Growth Rate of Inhalers from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Generic Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.2 USA Generic Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.3 USA Generic Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Generic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Generic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Generic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Generic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Generic Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Generic Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Oral
-
3.4.2 Market Size and Growth Rate of Injectables
-
3.4.3 Market Size and Growth Rate of Dermal/Topical
-
3.4.4 Market Size and Growth Rate of Inhalers
4 Segmentation of Generic Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Generic Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Generic Drugs in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Generic Drugs in Retail Pharmacies
-
4.4.3 Market Size and Growth Rate of Generic Drugs in Others
5 Market Analysis by Regions
-
5.1 USA Generic Drugs Production Analysis by Regions
-
5.2 USA Generic Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Generic Drugs Landscape Analysis
-
6.1 West USA Generic Drugs Landscape Analysis by Major Types
-
6.2 West USA Generic Drugs Landscape Analysis by Major End-Users
7 South USA Generic Drugs Landscape Analysis
-
7.1 South USA Generic Drugs Landscape Analysis by Major Types
-
7.2 South USA Generic Drugs Landscape Analysis by Major End-Users
8 Middle West USA Generic Drugs Landscape Analysis
-
8.1 Middle West USA Generic Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Generic Drugs Landscape Analysis by Major End-Users
9 Northeast USA Generic Drugs Landscape Analysis
-
9.1 Northeast USA Generic Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Generic Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Pfizer (Hospira)
-
10.1.1 Pfizer (Hospira) Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Valeant
-
10.2.1 Valeant Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Apotex
-
10.3.1 Apotex Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Stada Arzneimittel
-
10.4.1 Stada Arzneimittel Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Mylan
-
10.5.1 Mylan Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Cipla
-
10.6.1 Cipla Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Zydus Cadila
-
10.7.1 Zydus Cadila Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Lupin
-
10.8.1 Lupin Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Fresenius Kabi
-
10.9.1 Fresenius Kabi Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 ENDO (Par Pharmaceutical)
-
10.10.1 ENDO (Par Pharmaceutical) Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Nichi-Iko Pharmaceutical
-
10.11.1 Nichi-Iko Pharmaceutical Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Novartis - Sandoz
-
10.12.1 Novartis - Sandoz Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Aurobindo
-
10.13.1 Aurobindo Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Krka Group
-
10.14.1 Krka Group Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Sun Pharmaceutical
-
10.15.1 Sun Pharmaceutical Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Aspen
-
10.16.1 Aspen Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
-
10.17 Hikma
-
10.17.1 Hikma Company Profile and Recent Development
-
10.17.2 Market Performance
-
10.17.3 Product and Service Introduction
-
10.18 Teva
-
10.18.1 Teva Company Profile and Recent Development
-
10.18.2 Market Performance
-
10.18.3 Product and Service Introduction
-
10.19 Sanofi
-
10.19.1 Sanofi Company Profile and Recent Development
-
10.19.2 Market Performance
-
10.19.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Generic Drugs Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure USA Generic Drugs Market Size and Growth Rate of Injectables from 2016 to 2027
-
Figure USA Generic Drugs Market Size and Growth Rate of Dermal/Topical from 2016 to 2027
-
Figure USA Generic Drugs Market Size and Growth Rate of Inhalers from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Generic Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure USA Generic Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure USA Generic Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Generic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Generic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Generic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Generic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Generic Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Generic Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Generic Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Generic Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Injectables
-
Figure Market Size and Growth Rate of Dermal/Topical
-
Figure Market Size and Growth Rate of Inhalers
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Generic Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Generic Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Others
-
Table USA Generic Drugs Production by Regions
-
Table USA Generic Drugs Production Share by Regions
-
Figure USA Generic Drugs Production Share by Regions in 2016
-
Figure USA Generic Drugs Production Share by Regions in 2021
-
Figure USA Generic Drugs Production Share by Regions in 2027
-
Table USA Generic Drugs Consumption by Regions
-
Table USA Generic Drugs Consumption Share by Regions
-
Figure USA Generic Drugs Consumption Share by Regions in 2016
-
Figure USA Generic Drugs Consumption Share by Regions in 2021
-
Figure USA Generic Drugs Consumption Share by Regions in 2027
-
Table West USA Generic Drugs Consumption by Types from 2016 to 2027
-
Table West USA Generic Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Generic Drugs Consumption Share by Types in 2016
-
Figure West USA Generic Drugs Consumption Share by Types in 2021
-
Figure West USA Generic Drugs Consumption Share by Types in 2027
-
Table West USA Generic Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Generic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Generic Drugs Consumption Share by End-Users in 2016
-
Figure West USA Generic Drugs Consumption Share by End-Users in 2021
-
Figure West USA Generic Drugs Consumption Share by End-Users in 2027
-
Table South USA Generic Drugs Consumption by Types from 2016 to 2027
-
Table South USA Generic Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Generic Drugs Consumption Share by Types in 2016
-
Figure South USA Generic Drugs Consumption Share by Types in 2021
-
Figure South USA Generic Drugs Consumption Share by Types in 2027
-
Table South USA Generic Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Generic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Generic Drugs Consumption Share by End-Users in 2016
-
Figure South USA Generic Drugs Consumption Share by End-Users in 2021
-
Figure South USA Generic Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Generic Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Generic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Generic Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Generic Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Generic Drugs Consumption Share by Types in 2027
-
Table Middle West USA Generic Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Generic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Generic Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Generic Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Generic Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Generic Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Generic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Generic Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Generic Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Generic Drugs Consumption Share by Types in 2027
-
Table Northeast USA Generic Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Generic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Generic Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Generic Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Generic Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Pfizer (Hospira)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer (Hospira)
-
Figure Sales and Growth Rate Analysis of Pfizer (Hospira)
-
Figure Revenue and Market Share Analysis of Pfizer (Hospira)
-
Table Product and Service Introduction of Pfizer (Hospira)
-
Table Company Profile and Development Status of Valeant
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant
-
Figure Sales and Growth Rate Analysis of Valeant
-
Figure Revenue and Market Share Analysis of Valeant
-
Table Product and Service Introduction of Valeant
-
Table Company Profile and Development Status of Apotex
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex
-
Figure Sales and Growth Rate Analysis of Apotex
-
Figure Revenue and Market Share Analysis of Apotex
-
Table Product and Service Introduction of Apotex
-
Table Company Profile and Development Status of Stada Arzneimittel
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stada Arzneimittel
-
Figure Sales and Growth Rate Analysis of Stada Arzneimittel
-
Figure Revenue and Market Share Analysis of Stada Arzneimittel
-
Table Product and Service Introduction of Stada Arzneimittel
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Cipla
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla
-
Figure Sales and Growth Rate Analysis of Cipla
-
Figure Revenue and Market Share Analysis of Cipla
-
Table Product and Service Introduction of Cipla
-
Table Company Profile and Development Status of Zydus Cadila
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zydus Cadila
-
Figure Sales and Growth Rate Analysis of Zydus Cadila
-
Figure Revenue and Market Share Analysis of Zydus Cadila
-
Table Product and Service Introduction of Zydus Cadila
-
Table Company Profile and Development Status of Lupin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin
-
Figure Sales and Growth Rate Analysis of Lupin
-
Figure Revenue and Market Share Analysis of Lupin
-
Table Product and Service Introduction of Lupin
-
Table Company Profile and Development Status of Fresenius Kabi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Kabi
-
Figure Sales and Growth Rate Analysis of Fresenius Kabi
-
Figure Revenue and Market Share Analysis of Fresenius Kabi
-
Table Product and Service Introduction of Fresenius Kabi
-
Table Company Profile and Development Status of ENDO (Par Pharmaceutical)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ENDO (Par Pharmaceutical)
-
Figure Sales and Growth Rate Analysis of ENDO (Par Pharmaceutical)
-
Figure Revenue and Market Share Analysis of ENDO (Par Pharmaceutical)
-
Table Product and Service Introduction of ENDO (Par Pharmaceutical)
-
Table Company Profile and Development Status of Nichi-Iko Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nichi-Iko Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Nichi-Iko Pharmaceutical
-
Figure Revenue and Market Share Analysis of Nichi-Iko Pharmaceutical
-
Table Product and Service Introduction of Nichi-Iko Pharmaceutical
-
Table Company Profile and Development Status of Novartis - Sandoz
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis - Sandoz
-
Figure Sales and Growth Rate Analysis of Novartis - Sandoz
-
Figure Revenue and Market Share Analysis of Novartis - Sandoz
-
Table Product and Service Introduction of Novartis - Sandoz
-
Table Company Profile and Development Status of Aurobindo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo
-
Figure Sales and Growth Rate Analysis of Aurobindo
-
Figure Revenue and Market Share Analysis of Aurobindo
-
Table Product and Service Introduction of Aurobindo
-
Table Company Profile and Development Status of Krka Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Krka Group
-
Figure Sales and Growth Rate Analysis of Krka Group
-
Figure Revenue and Market Share Analysis of Krka Group
-
Table Product and Service Introduction of Krka Group
-
Table Company Profile and Development Status of Sun Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical
-
Figure Revenue and Market Share Analysis of Sun Pharmaceutical
-
Table Product and Service Introduction of Sun Pharmaceutical
-
Table Company Profile and Development Status of Aspen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen
-
Figure Sales and Growth Rate Analysis of Aspen
-
Figure Revenue and Market Share Analysis of Aspen
-
Table Product and Service Introduction of Aspen
-
Table Company Profile and Development Status of Hikma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hikma
-
Figure Sales and Growth Rate Analysis of Hikma
-
Figure Revenue and Market Share Analysis of Hikma
-
Table Product and Service Introduction of Hikma
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
